Skip to content

Clinical trials

Phase 2 Polymyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polymyositis Phase: Phase 2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20081
20101
20111
20132
20141
20202
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kezar Life Sciences, Inc.2
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2
Novartis Pharmaceuticals2
Amgen1
Chester Oddis1
EMD Serono Research & Development Institute, Inc.1
Immunoforge Co. Ltd.1
Karolinska Institutet1
NYU Langone Health1
National Institute of Neurological Disorders and Stroke (NINDS)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polymyositis17
Dermatomyositis15
Myositis9
Myositis, Inclusion Body3
Muscle Weakness2
Muscular Diseases2
Musculoskeletal Diseases2
Arthritis, Juvenile1
Arthritis, Psoriatic1
Arthritis, Rheumatoid1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.